Jordan Olsen Herron
Nurse Practitioner · Cartersville, GANPI 1871272658
Payments from drug & device makers
Across 125 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$487
- Sanofi$386
- Takeda Pharmaceuticals U.S.A., Inc.$345
- Gilead$255
- Grifols USA, LLC$179
- GSK$157
- plus $649 from 17 others
What the payments were for
- Food & beverage$2,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 30 | $487 |
| Sanofi | 21 | $386 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $345 |
| Gilead | 12 | $255 |
| Grifols USA, LLC | 8 | $179 |
| GSK | 8 | $157 |
| Paratek Pharmaceuticals, Inc. | 6 | $123 |
| Pfizer | 4 | $96 |
| Melinta Therapeutics, LLC | 4 | $66 |
| Biocryst US Sales Co., LLC | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| Organogenesis Inc. | 1 | $31 |
| Ionis Pharmaceuticals, Inc. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $28 |
| AbbVie | 1 | $22 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $18 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $17 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| Merck | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
How this compares
$2,458 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DovatoDolutegravir Sodium/Lamivudine | 56 | $177,113 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 20 | $79,540 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 19 | $75,378 |
| Doxycycline Hyclate | 54 | $663 |
| Ethambutol Hcl | 12 | $514 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $462 |
| Fluconazole | 16 | $429 |
| Montelukast Sodium | 61 | $320 |
| Azithromycin | 14 | $296 |
| Fluticasone Propionate | 14 | $150 |
| Levofloxacin | 23 | $143 |
| Famotidine | 13 | $139 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $112 |
| Cephalexin | 11 | $96 |
| Amoxicillin | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato, Triumeq | $487 | $256,65476 claims |
| GileadBiktarvy | $255 | $75,37819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Cartersville
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.